Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentin Fuster

Showing results (651-660 of 913) with videos related to

Pageof 92
Sort By:
Journal of the American College of Cardiology|July 5, 2005
Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imagingRoberto Corti, Valentin Fuster, Zahi A Fayad, et al.
Journal of the American College of Cardiology|October 19, 2004
Task force 3: Disclosure of relationships with commercial interests: policy for educational activities and publicationsAlice K Jacobs, Bruce D Lindsay, Bruce J Bellande, et al.
Journal of the American College of Cardiology|April 20, 2019
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial EnergeticsCarlos G Santos-Gallego, Juan Antonio Requena-Ibanez, Rodolfo San Antonio, et al.
Circulation. Cardiovascular Interventions|August 4, 2017
Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With TicagrelorM Urooj Zafar, Donald A Smith, Usman Baber, et al.
Nature Cardiovascular Research|August 28, 2024
Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failureChristiane E Angermann, Carlos G Santos-Gallego, Juan Antonio Requena-Ibanez, et al.
Journal of the American College of Cardiology|March 5, 2025
Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art ReviewFrans J Beerkens, Gilbert H L Tang, Annapoorna S Kini, et al.
American Heart Journal|September 25, 2024
Subclinical atherosclerosis and brain health in midlife: Rationale and design of the PESA-Brain studyCatarina Tristão-Pereira, Valentin Fuster, Alejandro Lopez-Jimenez, et al.
JACC. Cardiovascular Imaging|May 16, 2009
Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosisMichael J Lipinski, Juan C Frias, Vardan Amirbekian, et al.
European Heart Journal|June 12, 2004
Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, GreeceJohannes A Schaar, James E Muller, Erling Falk, et al.
Nature Clinical Practice. Cardiovascular Medicine|August 20, 2008
The use of high-sensitivity assays for C-reactive protein in clinical practiceKiran Musunuru, Brian G Kral, Roger S Blumenthal, et al.
Pageof 92

Showing results (651-660 of 913) with videos related to

Sort By:
Pageof 92
Journal of the American College of Cardiology|July 5, 2005
Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imagingRoberto Corti, Valentin Fuster, Zahi A Fayad, et al.
Journal of the American College of Cardiology|October 19, 2004
Task force 3: Disclosure of relationships with commercial interests: policy for educational activities and publicationsAlice K Jacobs, Bruce D Lindsay, Bruce J Bellande, et al.
Journal of the American College of Cardiology|April 20, 2019
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial EnergeticsCarlos G Santos-Gallego, Juan Antonio Requena-Ibanez, Rodolfo San Antonio, et al.
Circulation. Cardiovascular Interventions|August 4, 2017
Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With TicagrelorM Urooj Zafar, Donald A Smith, Usman Baber, et al.
Nature Cardiovascular Research|August 28, 2024
Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failureChristiane E Angermann, Carlos G Santos-Gallego, Juan Antonio Requena-Ibanez, et al.
Journal of the American College of Cardiology|March 5, 2025
Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art ReviewFrans J Beerkens, Gilbert H L Tang, Annapoorna S Kini, et al.
American Heart Journal|September 25, 2024
Subclinical atherosclerosis and brain health in midlife: Rationale and design of the PESA-Brain studyCatarina Tristão-Pereira, Valentin Fuster, Alejandro Lopez-Jimenez, et al.
JACC. Cardiovascular Imaging|May 16, 2009
Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosisMichael J Lipinski, Juan C Frias, Vardan Amirbekian, et al.
European Heart Journal|June 12, 2004
Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, GreeceJohannes A Schaar, James E Muller, Erling Falk, et al.
Nature Clinical Practice. Cardiovascular Medicine|August 20, 2008
The use of high-sensitivity assays for C-reactive protein in clinical practiceKiran Musunuru, Brian G Kral, Roger S Blumenthal, et al.
Pageof 92